SOX2 Expression Does Not Guarantee Cancer Stem Cell-like Characteristics in Lung Adenocarcinoma

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Targeting cancer stemness is crucial for effective cancer therapy.
• SOX2, a stem cell factor, is implicated in cancer stem cell (CSC) characteristics and malignancy.
• Its role in lung adenocarcinoma (LUAD) patient survival is complex, necessitating further investigation.

Purpose of the Study:

• To investigate the essentiality of SOX2 in maintaining CSC-like properties in LUAD.
• To clarify the functional role of SOX2 in LUAD cancer stemness.
• To evaluate the impact of SOX2 manipulation on CSC traits in LUAD cell lines.

Main Methods:

• CRISPR/Cas9 system was used to generate SOX2 knockouts in LUAD cell lines (A549, H358, HCC827).
• SOX2 knockdown was performed using conditional shRNA.
• CSC characteristics including proliferation, tumor sphere formation, invasion, migration, and therapy resistance were assessed.
• Rescue experiments with shRNA-resistant SOX2 were conducted.

Main Results:

• SOX2 knockout did not alter CSC characteristics in LUAD cells.
• SOX2 knockdown significantly reduced CSC traits.
• Loss-of-function effects from knockdown were not rescued by shRNA-resistant SOX2, indicating potential protein level-independent mechanisms or off-target effects.
• SOX2 is not universally required for CSC properties in LUAD.

Conclusions:

• SOX2 is not absolutely essential for maintaining CSC-like properties in LUAD.
• Findings highlight the need to consider cancer subtype- and context-dependent roles of SOX2.
• Targeting SOX2 overexpression requires careful evaluation of its specific contribution to cancer stemness in different cancer types.